Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in heart failure patients with reduced ejection fraction: Comparison with soluble AXL and BNP.
Batlle M, Campos B, Farrero M, Cardona M, González B, Castel MA, Ortiz J, Roig E, Pulgarín MJ, Ramírez J, Bedini JL, Sabaté M, García de Frutos P, Pérez-Villa F. Batlle M, et al. Among authors: ortiz j. Int J Cardiol. 2016 Dec 15;225:113-119. doi: 10.1016/j.ijcard.2016.09.079. Epub 2016 Sep 28. Int J Cardiol. 2016. PMID: 27718443
AXL receptor tyrosine kinase is increased in patients with heart failure.
Batlle M, Recarte-Pelz P, Roig E, Castel MA, Cardona M, Farrero M, Ortiz JT, Campos B, Pulgarín MJ, Ramírez J, Pérez-Villa F, García de Frutos P. Batlle M, et al. Among authors: ortiz jt. Int J Cardiol. 2014 May 15;173(3):402-9. doi: 10.1016/j.ijcard.2014.03.016. Epub 2014 Mar 15. Int J Cardiol. 2014. PMID: 24681018 Free article.
Data on clinical characteristics of a heart failure patients' cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP.
Batlle M, Campos B, Farrero M, Cardona M, González B, Castel MA, Ortiz J, Roig E, Pulgarín MJ, Ramírez J, Bedini JL, Sabaté M, de Frutos PG, Pérez-Villa F. Batlle M, et al. Among authors: ortiz j. Data Brief. 2016 Nov 3;9:876-882. doi: 10.1016/j.dib.2016.10.020. eCollection 2016 Dec. Data Brief. 2016. PMID: 27872884 Free PMC article.
Randomized clinical trial of the effectiveness of a home-based intervention in patients with heart failure: the IC-DOM study.
Brotons C, Falces C, Alegre J, Ballarín E, Casanovas J, Catà T, Martínez M, Moral I, Ortiz J, Pérez E, Rayó E, Recio J, Roig E, Vidal X. Brotons C, et al. Among authors: ortiz j. Rev Esp Cardiol. 2009 Apr;62(4):400-8. doi: 10.1016/s1885-5857(09)71667-6. Rev Esp Cardiol. 2009. PMID: 19401125 Free article. Clinical Trial. English, Spanish.
Exercise-related severe cardiac events.
Vicent L, Ariza-Solé A, González-Juanatey JR, Uribarri A, Ortiz J, López de Sá E, Sans-Roselló J, Querol CT, Codina P, Sousa-Casasnovas I, Martínez-Sellés M; Cardiac Arrest and Myocardial Infarction Notified After Marathon Or Similar effort (CAMINAMOS) registry. Vicent L, et al. Among authors: ortiz j. Scand J Med Sci Sports. 2018 Apr;28(4):1404-1411. doi: 10.1111/sms.13037. Epub 2018 Jan 8. Scand J Med Sci Sports. 2018. PMID: 29237243
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain.
Chaparro M, Barreiro-de Acosta M, Benítez JM, Cabriada JL, Casanova MJ, Ceballos D, Esteve M, Fernández H, Ginard D, Gomollón F, Lorente R, Nos P, Riestra S, Rivero M, Robledo P, Rodríguez C, Sicilia B, Torrella E, Garre A, García-Esquinas E, Rodríguez-Artalejo F, Gisbert JP; EpidemIBD study group of GETECCU. Chaparro M, et al. Therap Adv Gastroenterol. 2019 May 21;12:1756284819847034. doi: 10.1177/1756284819847034. eCollection 2019. Therap Adv Gastroenterol. 2019. PMID: 31205485 Free PMC article.
Risk-adjusted early invasive strategy in patients with non-ST-segment elevation acute coronary syndrome in Intensive Cardiac Care Units.
Llaó I, Gómez-Hospital JA, Aboal J, Garcia C, Montero S, Sambola A, Ortiz J, Tomás C, Bonet G, Viñas D, Oliveras T, Sans-Roselló J, Cantalapiedra J, Andrea R, Hernández I, Pérez-Rodriguez M, Gual M, Cequier A, Ariza-Solé A; en representación de los investigadores del Grup de Treball de Cures Agudes Cardiològiques de la Societat Catalana de Cardiologia. Llaó I, et al. Among authors: ortiz j. Med Intensiva (Engl Ed). 2020 Nov;44(8):475-484. doi: 10.1016/j.medin.2019.06.006. Epub 2019 Jul 27. Med Intensiva (Engl Ed). 2020. PMID: 31362838 English, Spanish.
2,236 results